Next Article in Journal
Machine Perfusion Across Marginal Liver Grafts: Benefits and Challenges
Previous Article in Journal
Personalized Diabetes Therapy Part 1—Functional Phenotyping as a Conceptual Basis for Individualized Treatment
 
 
Expression of Concern: J. Pers. Med. 2022, 12(9), 1536.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Expression of Concern

Expression of Concern: Dellino et al. Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case–Control Analysis. J. Pers. Med. 2022, 12, 1536

by
Journal of Personalized Medicine Editorial Office
MDPI, Grosspeteranlage 5, 4052 Basel, Switzerland
J. Pers. Med. 2026, 16(4), 227; https://doi.org/10.3390/jpm16040227
Submission received: 13 April 2026 / Accepted: 14 April 2026 / Published: 20 April 2026
With this notice, the Journal of Personalized Medicine Editorial Office and Editorial Board wishes to alert readers to concerns related to this article [1]. Following publication concerns were raised regarding data integrity and reporting, including dataset structure (duplicated participant identifiers), enrollment documentation, and outcome interpretation. The investigation is being coordinated by the Editorial Office with the involvement of the Editorial Board. Once this process is complete, the Editorial Office will provide an update on this situation and announce any post-publication modification deemed to be necessary, as per MDPI’s Updating Published Papers policy.

Reference

  1. Dellino, M.; Cascardi, E.; Leoni, C.; Fortunato, F.; Fusco, A.; Tinelli, R.; Cazzato, G.; Scacco, S.; Gnoni, A.; Scilimati, A.; et al. Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case–Control Analysis. J. Pers. Med. 2022, 12, 1536. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Journal of Personalized Medicine Editorial Office. Expression of Concern: Dellino et al. Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case–Control Analysis. J. Pers. Med. 2022, 12, 1536. J. Pers. Med. 2026, 16, 227. https://doi.org/10.3390/jpm16040227

AMA Style

Journal of Personalized Medicine Editorial Office. Expression of Concern: Dellino et al. Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case–Control Analysis. J. Pers. Med. 2022, 12, 1536. Journal of Personalized Medicine. 2026; 16(4):227. https://doi.org/10.3390/jpm16040227

Chicago/Turabian Style

Journal of Personalized Medicine Editorial Office. 2026. "Expression of Concern: Dellino et al. Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case–Control Analysis. J. Pers. Med. 2022, 12, 1536" Journal of Personalized Medicine 16, no. 4: 227. https://doi.org/10.3390/jpm16040227

APA Style

Journal of Personalized Medicine Editorial Office. (2026). Expression of Concern: Dellino et al. Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case–Control Analysis. J. Pers. Med. 2022, 12, 1536. Journal of Personalized Medicine, 16(4), 227. https://doi.org/10.3390/jpm16040227

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop